← back to search

Lindsay M. Morton

National Institutes of Health · US
Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, and Viral-associated cancers and disorders.
h-index
68
citations
19,273
works
481
NIH funding
primary concept
email

Recent publications

A Historical Survey of Key Epidemiological Studies of Ionizing Radiation Exposure
Radiation Research 2024cited by 19position: middledoi
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding
The American Journal of Human Genetics 2023cited by 11position: middledoi
Inflated expectations: Rare-variant association analysis using public controls
PLoS ONE 2023cited by 9position: middledoi
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
Leukemia 2023cited by 1position: middledoi
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
Leukemia 2022cited by 32position: middledoi
Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors
JAMA Oncology 2022cited by 16position: middledoi
A Novel Locus on 6p21.2 for Cancer Treatment–Induced Cardiac Dysfunction Among Childhood Cancer Survivors
JNCI Journal of the National Cancer Institute 2022cited by 12position: middledoi
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study
JNCI Cancer Spectrum 2021cited by 44position: middledoi
Contribution of Polygenic Risk to Hypertension Among Long-Term Survivors of Childhood Cancer
JACC CardioOncology 2021cited by 29position: middledoi
Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood Cancer
Cancer Epidemiology Biomarkers & Prevention 2021cited by 16position: middledoi
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Nature Genetics 2020cited by 727position: middledoi
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
JAMA Oncology 2020cited by 245position: middledoi
Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study
PLoS ONE 2020cited by 26position: middledoi
Subsequent Primary Neoplasms
Pediatric Clinics of North America 2020cited by 24position: lastdoi
Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor Study
JCO Precision Oncology 2020cited by 23position: firstdoi
Generalizability of “GWAS Hits” in Clinical Populations: Lessons from Childhood Cancer Survivors
The American Journal of Human Genetics 2020cited by 18position: middledoi
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma
PLoS ONE 2020cited by 10position: middledoi
Genetically Determined Height and Risk of Non-hodgkin Lymphoma
Frontiers in Oncology 2020cited by 9position: middledoi
Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use
JAMA Pediatrics 2019cited by 55position: middledoi
Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes
Genetic Epidemiology 2019cited by 39position: middledoi
Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell Carcinoma
Journal of Investigative Dermatology 2019cited by 23position: middledoi
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
Nature Communications 2018cited by 71position: middledoi
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes
Cancer Research 2018cited by 41position: middledoi
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Blood 2018cited by 32position: middledoi
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
Nature Communications 2018cited by 23position: middledoi
Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays
BMC Genomics 2018cited by 23position: middledoi
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Nature Communications 2017cited by 104position: middledoi
Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer
JNCI Journal of the National Cancer Institute 2017cited by 91position: firstdoi
Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma
Lupus Science & Medicine 2017cited by 27position: middledoi
A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy
JNCI Journal of the National Cancer Institute 2017cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Smita Bhatia · University of Alabama at Birmingham10 papers (2016–2023)Gregory T. Armstrong · Disco (Germany)10 papers (2014–2023)Leslie L. Robison · Datar Cancer Genetics (India)9 papers (2017–2023)Joshua N. Sampson · National Institutes of Health8 papers (2014–2023)Yutaka Yasui · Disco (Germany)6 papers (2017–2023)Yadav Sapkota · Texas Children's Hospital5 papers (2017–2021)Melissa M. Hudson · Disco (Germany)5 papers (2017–2021)Stephen J. Chanock · Cancer Genetics (United States)5 papers (2017–2023)Todd M. Gibson · National Institutes of Health4 papers (2013–2021)Sophia Wang · B.C. Women's Hospital & Health Centre4 papers (2014–2014)Rebecca M. Howell · The University of Texas MD Anderson Cancer Center4 papers (2013–2022)Rochelle E. Curtis · National Cancer Institute4 papers (2013–2019)Michael Arnold · University of Colorado Denver4 papers (2019–2022)Joseph P. Neglia · University of Minnesota4 papers (2019–2022)Jinghui Zhang · Southeast University4 papers (2017–2021)Lucie M. Turcotte · University of Minnesota, Twin Cities3 papers (2019–2022)Eleanor Kane · University of York3 papers (2014–2014)Dennis D. Weisenburger · University of Nebraska Medical Center3 papers (2013–2014)Susan A. Smith · The University of Texas MD Anderson Cancer Center3 papers (2013–2022)Eric A. Engels · National Cancer Institute3 papers (2013–2016)